News

There?s no way around it: Developing medicine is costly. The average drug takes about $2.6 billion to develop through FDA approval, according to the Tufts Center for the Study of Drug Development. With a price tag that high, securing venture capital (V… […]

Gene sequencing giant Illumina and Rady Children’s Institute for Genomic Medicine have helped launch an international program to standardize the use of genome sequencing in medicine. The Medical Genome Initiative, announced Tuesday, aims to turn wh… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–OFC 2019, the premier event in telecom and data center optics, being held 5-7 March at the San Diego Convention Center,… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/California?src=hash" target="_blank"gt;#Californialt;/agt;–Biocom appoints Christophe Schilling, Ph.D., as chair of the organization’s board of directors, makes add… […]

SAN DIEGO–(BUSINESS WIRE)–Eight leading health care and research organizations in the U.S. and Canada have signed an agreement to launch the Medical Genome Initiative, a consortium that will work to expand access to high-quality clinical whole genome… […]

As the fast-moving Ebola virus sweeps through eastern Congo, scientists are braving into war zones hoping to test new medicines ? including one designed in San Diego ? in sick patients there. Despite civil unrest in the region, Doctors Without Bord… […]

LA JOLLA, Calif.–(BUSINESS WIRE)–Trio Health, a leading provider of retrospective observational data on real world patients, today announced results from several of its research programs that reveal critical, and often counterintuitive, insights rega… […]

LA JOLLA?The Salk Institute Board of Trustees is pleased to announce its two newest members, David Dolby and Mark Knickrehm, both innovative leaders in business and technology.
The post Technology and business giants David Dolby and Mark Knickrehm join… […]

Novartis has agreed to pay $150 million to Ionis Pharmaceuticals and Boston-based Akcea Therapeutics for the rights to a clinical-stage drug meant to treat patients with abnormally high levels of a protein that is considered a risk factor for cardiovas… […]

Novartis will pay $150 million to license a heart disease medication discovered by Carlsbad?s Ionis Pharmaceuticals, the Swiss drug giant said Monday. The experimental drug was co-developed by Ionis with its majority-owned subsidiary Akcea Therapeu… […]

Section 32, the venture capital fund based in San Diego?s Cardiff-by-the-Sea community, has raised nearly $200 million for its second fund. A document filed with securities regulators Friday shed light on comments made the previous week to Xconomy by S… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–New work leveraging machine learning could increase the efficiency of optical telecommunications networks. As our world… […]

LA JOLLA?As cancer death rates drop overall, doctors have noted a frightening anomaly: deaths from colorectal cancer in people under 55 appear to be creeping up. According to the American Cancer Society, deaths in this younger group increased by 1 perc… […]

The software of Portfolium, a San Diego startup that hosts online portfolios for students trying to showcase their achievements to potential employers, is set to join the portfolio of Utah educational software company Instructure. Instructure (NYSE: IN… […]

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OFC2019?src=hash" target="_blank"gt;#OFC2019lt;/agt;–With the advent of 5G and IoT, technologies must interoperate. OFC 2019 features live multivendor interoperabil… […]

LA JOLLA?The medicinal powers of aspirin, digitalis, and the anti-malarial artemisinin all come from plants. A Salk Institute discovery of a potent neuroprotective and anti-inflammatory chemical in a native California shrub may lead to a treatment for … […]

Gene therapy increased lifespan 25 percent in a mouse model of the fatal accelerated aging disease progeria, Salk Institute scientists reported Monday. Using the powerful CRISPR gene editing technology, scientists prevented the formation of a toxic… […]

LA JOLLA?Aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer?s disease, to name a few. This makes the need for anti-aging therapies all the more urgent. Now, Salk Institute researchers h… […]